CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-14 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −977 | $30.00 | $29K | 164,269 |
| 2025-03-14 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −2,255 | $30.00 | $68K | 124,421 |
| 2025-03-11 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −15,387 | $30.00 | $462K | 126,676 |
| 2025-03-11 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −10,445 | $30.01 | $313K | 165,246 |
| 2025-03-07 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −1,504 | $30.00 | $45K | 175,691 |
| 2025-03-07 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −2,348 | $30.00 | $70K | 142,063 |
| 2025-03-06 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −15,387 | $30.00 | $462K | 126,676 |
| 2025-03-06 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −1,949 | $30.00 | $58K | 177,195 |
| 2025-03-06 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −3,295 | $30.00 | $99K | 144,411 |
| 2025-03-06 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −26,067 | $28.50 | $743K | 108,137 |
| 2025-03-05 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −20,000 | $28.03 | $561K | 134,204 |
| 2025-03-04 | Kuhlmann Shirley R. EVP and General Counsel | Option exercise | +40,000 | $24.03 | $961K | 194,204 |
| 2025-03-04 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −40,000 | $28.08 | $1.1M | 154,204 |
| 2025-03-04 | Kuhlmann Shirley R. EVP and General Counsel | Option exercise · Stock Option (Right to Purchase) | −40,000 | 0 | ||
| 2025-02-10 | Heffernan Michael Thomas Director | Grant or award | +4,820 | 50,328 | ||
| 2025-02-10 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +33,762 | 88,326 | ||
| 2025-02-10 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +5,313 | 93,639 | ||
| 2025-02-10 | Smith Thomas B EVP and Chief Medical Officer | Shares withheld for taxes | −1,498 | $30.52 | $46K | 92,141 |
| 2025-02-10 | Smith Thomas B EVP and Chief Medical Officer | Shares withheld for taxes | −4,399 | $30.52 | $134K | 87,742 |
| 2025-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +45,016 | 150,918 |
Page 5 of 24 · 462 trades